Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults-Reference-Cited by-同舟云学术

Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults

Published:2022-03-31 Issue:5 Volume:28 Page:1031-1041
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Killingley Ben,Mann Alex J.^ORCID,Kalinova Mariya,Boyers Alison,Goonawardane Niluka,Zhou Jie,Lindsell Kate,Hare Samanjit S.,Brown Jonathan^ORCID,Frise Rebecca,Smith Emma,Hopkins Claire,Noulin Nicolas,Löndt Brandon,Wilkinson Tom,Harden Stephen,McShane Helen^ORCID,Baillet Mark,Gilbert Anthony,Jacobs Michael,Charman Christine,Mande Priya,Nguyen-Van-Tam Jonathan S.,Semple Malcolm G.^ORCID,Read Robert C.^ORCID,Ferguson Neil M.^ORCID,Openshaw Peter J.^ORCID,Rapeport Garth^ORCID,Barclay Wendy S.^ORCID,Catchpole Andrew P.,Chiu Christopher^ORCID

Funder

Her Majesty’s Government UK through the Department of Business Energy and Industrial Strategy

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.nature.com/articles/s41591-022-01780-9.pdf

Reference55 articles.

1. Drake, T. M. et al. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet 398, 223–237 (2021).

2. Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99–111 (2021).

3. Thomas, S. J. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 Months. N. Engl. J. Med. 385, 1761–1773 (2021).